Biopesticide products maker Eden Research and natural said its commercial partner, Eastman Chemical had received full authorisation to sell the company’s nematicide formulation from the Belgian Ministry of Agriculture. Authorisation of Eden’s nematicide formulation in Belgium, marketed as Cedroz by Eastman, where the primary use would be in greenhouses, was a 'very good starting point for authorisations to come in other EU Member States,' the company said. 'Unlike many other products, Cedroz is residue-free and has a zero-day pre-harvest interval, thereby allowing applications right up to harvest, if required,' it added. At 9:40am: (LON:EDEN) Eden Research plc share price was +0.28p at 8.25p
Sign up to our
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
UK 350 Risers and Fallers
Tweets not available.